NAROPIN - 63323-286-20 - (ROPIVACAINE HYDROCHLORIDE MONOHYDRATE)

Alphabetical Index


Drug Information of NAROPIN

Product NDC: 63323-286
Proprietary Name: NAROPIN
Non Proprietary Name: ROPIVACAINE HYDROCHLORIDE MONOHYDRATE
Active Ingredient(s): 5    mg/mL & nbsp;   ROPIVACAINE HYDROCHLORIDE MONOHYDRATE
Administration Route(s): EPIDURAL; INFILTRATION; PERINEURAL
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of NAROPIN

Product NDC: 63323-286
Labeler Name: APP Pharmaceuticals, LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA020533
Marketing Category: NDA
Start Marketing Date: 20090804

Package Information of NAROPIN

Package NDC: 63323-286-20
Package Description: 5 BLISTER PACK in 1 BOX (63323-286-20) > 1 AMPULE in 1 BLISTER PACK > 20 mL in 1 AMPULE

NDC Information of NAROPIN

NDC Code 63323-286-20
Proprietary Name NAROPIN
Package Description 5 BLISTER PACK in 1 BOX (63323-286-20) > 1 AMPULE in 1 BLISTER PACK > 20 mL in 1 AMPULE
Product NDC 63323-286
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name ROPIVACAINE HYDROCHLORIDE MONOHYDRATE
Dosage Form Name INJECTION, SOLUTION
Route Name EPIDURAL; INFILTRATION; PERINEURAL
Start Marketing Date 20090804
Marketing Category Name NDA
Labeler Name APP Pharmaceuticals, LLC
Substance Name ROPIVACAINE HYDROCHLORIDE MONOHYDRATE
Strength Number 5
Strength Unit mg/mL
Pharmaceutical Classes Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Local Anesthesia [PE]

Complete Information of NAROPIN


General Information